rs1417036453
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PVS1PM2PP3PP5_Very_Strong
The NM_001099404.2(SCN5A):c.1603C>T(p.Arg535Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001099404.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.1603C>T | p.Arg535Ter | stop_gained | 12/28 | ENST00000413689.6 | |
SCN5A | NM_000335.5 | c.1603C>T | p.Arg535Ter | stop_gained | 12/28 | ENST00000423572.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.1603C>T | p.Arg535Ter | stop_gained | 12/28 | 5 | NM_001099404.2 | P4 | |
SCN5A | ENST00000423572.7 | c.1603C>T | p.Arg535Ter | stop_gained | 12/28 | 1 | NM_000335.5 | A1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 247858Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134558
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461302Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726900
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | May 07, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change creates a premature translational stop signal (p.Arg535*) in the SCN5A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCN5A are known to be pathogenic (PMID: 20129283, 22789973). This variant is present in population databases (no rsID available, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with SCN5A-related arrhythmia (PMID: 12106943, 20129283, 23631430). ClinVar contains an entry for this variant (Variation ID: 517279). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Mar 07, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 25, 2021 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate a damaging effect on channel function (Keller et al., 2005); Not observed at significant frequency in large population cohorts (gnomAD); Reported in ClinVar as a pathogenic variant (ClinVar Variant ID# 517279; ClinVar); This variant is associated with the following publications: (PMID: 19606473, 23631430, 25525159, 19251209, 20129283, 28482396, 31043699, 30193851, 31447099, 33131149, 20031634, 15890323, 30662450, 34135346, 33087929, 12106943) - |
SCN5A-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 20, 2023 | The SCN5A c.1603C>T (p.Arg535Ter) nonsense variant results in the substitution of arginine at amino acid position 535 with a stop codon. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. Across a selection of the available literature, this variant has been identified in at least ten unrelated individuals - seven with Brugada syndrome, and one each with long QT syndrome, sudden infant death syndrome, and sudden adult cardiac death (PMID: 12106943; PMID: 15890323; PMID: 20031634; PMID: 20129283; PMID: 23631430; PMID: 25757662; PMID: 34076677). Segregation of the variant with the disorder was noted in at least one family (PMID: 20031634). This variant is reported in the Genome Aggregation Database in one allele at a frequency of 0.000056 in the East Asian population (version 2.1.1). Based on the available evidence, the c.1603C>T (p.Arg535Ter) variant is classified as pathogenic for SCN5A-related disorders. - |
Primary familial dilated cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | - | - - |
Brugada syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 28, 2020 | The p.Arg535X variant in SCN5A has been reported in at least 9 individuals (8 with Brugada syndrome and 1 referred for Long QT syndrome testing), and segregated with disease in 4 affected relatives from 1 family (Smits 2002, Keller 2005, Probst 2009, Meregalli 2009, Kapplinger 2010, Lieve 2013). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID: 517279) and has been identified in 0.006% (1/17212) of East Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org/). This nonsense variant leads to a premature termination codon at position 535, which leads to a truncated protein that impacts protein function as shown by in vitro studies (Keller 2005). Heterozygous loss of function variants in the SCN5A gene have been reported in individuals with Brugada syndrome (Kapplinger 2010), DCM (Olson 2005), ventricular fibrillation (Chen 1998), as well as AV block and cardiac conduction defects (Baruteau 2012). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant Brugada syndrome. ACMG/AMP criteria applied: PVS1, PM2, PS4_Moderate, PP1. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 16, 2023 | The p.R535* pathogenic mutation (also known as c.1603C>T), located in coding exon 11 of the SCN5A gene, results from a C to T substitution at nucleotide position 1603. This changes the amino acid from an arginine to a stop codon within coding exon 11. This alteration has been reported in several Brugada syndrome (BrS) cohorts and has been shown to segregate with disease in one family (Probst V et al. Circ Cardiovasc Genet. 2009;2:552-7; Kapplinger JD et al. Heart Rhythm. 2010;7:33-46). It has also been detected in long QT syndrome (LQTS) and sudden infant death syndrome (SIDS) cohorts (Lieve KV et al. Genet Test Mol Biomarkers. 2013;17:553-61; Winkel BG et al. Heart Rhythm. 2015;12:1241-9). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Cardiac arrhythmia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Oct 03, 2023 | This variant changes 1 nucleotide in exon 12 of the SCN5A gene, creating a premature translation stop signal. A functional study has shown that this variant results in a truncated protein and leads to a complete loss of sodium current (PMID: 15890323). This variant has been reported in over ten individuals affected with Brugada syndrome (PMID: 12106943, 15890323, 16643399, 19251209, 20031634, 32893267, 35331424) or suspected of having Brugada syndrome (PMID: 20129283, 35352813), and in an individual affected with sudden infant death syndrome (PMID: 25757662). This variant has been identified in 1/247858 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of SCN5A function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at